IS6845A - Pýridasínón aldósa afsýringarkljúfshindrar - Google Patents

Pýridasínón aldósa afsýringarkljúfshindrar

Info

Publication number: IS6845A
Authority: IS; Iceland
Prior art keywords: antacids; pyridazinone aldose; pyridazinone; aldose; aldose antacids
Prior art date: 2001-03-30

Application number

IS6845A

Other languages

English (en)

Other versions

IS2205B (is

Inventor

Lakshman Mylari Banavara

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-30

Filing date

2003-06-16

Publication date

2003-06-16

2003-06-16 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2003-06-16 Publication of IS6845A publication Critical patent/IS6845A/is

2007-02-15 Publication of IS2205B publication Critical patent/IS2205B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Cardiology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS6845A 2001-03-30 2003-06-16 Pýridasínón aldósa afsýringarkljúfshindrar IS2205B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28005101P	2001-03-30	2001-03-30
PCT/IB2002/000320 WO2002079198A1 (en)	2001-03-30	2002-01-31	Pyridazinone aldose reductase inhibitors

Publications (2)

Publication Number	Publication Date
IS6845A true IS6845A (is)	2003-06-16
IS2205B IS2205B (is)	2007-02-15

Family

ID=23071435

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IS6845A IS2205B (is)	2001-03-30	2003-06-16	Pýridasínón aldósa afsýringarkljúfshindrar
IS8251A IS8251A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar
IS8250A IS8250A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IS8251A IS8251A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar
IS8250A IS8250A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar

Country Status (43)

Country	Link
US (2)	US6579879B2 (is)
EP (3)	EP1373259B1 (is)
JP (1)	JP2004528319A (is)
KR (1)	KR100586138B1 (is)
CN (1)	CN1215067C (is)
AP (1)	AP2002002461A0 (is)
AR (1)	AR035798A1 (is)
AT (3)	ATE352551T1 (is)
AU (1)	AU2002226634B2 (is)
BG (1)	BG108179A (is)
BR (1)	BR0208571A (is)
CA (1)	CA2442476A1 (is)
CZ (1)	CZ20032563A3 (is)
DE (3)	DE60216823T2 (is)
DK (2)	DK1373259T3 (is)
EA (1)	EA006023B1 (is)
EC (1)	ECSP034671A (is)
EE (1)	EE200300470A (is)
ES (2)	ES2274369T3 (is)
GE (1)	GEP20053675B (is)
HR (1)	HRP20030752A2 (is)
HU (1)	HUP0303644A3 (is)
IL (1)	IL156462A0 (is)
IS (3)	IS2205B (is)
MA (1)	MA27003A1 (is)
MX (1)	MXPA03008850A (is)
MY (1)	MY134304A (is)
NO (1)	NO20034345L (is)
NZ (1)	NZ528406A (is)
OA (1)	OA12453A (is)
PA (1)	PA8541801A1 (is)
PE (1)	PE20030007A1 (is)
PL (1)	PL365294A1 (is)
PT (2)	PT1373259E (is)
SI (1)	SI1373259T1 (is)
SK (1)	SK11852003A3 (is)
TN (1)	TNSN02037A1 (is)
TW (1)	TWI245762B (is)
UA (1)	UA73236C2 (is)
UY (1)	UY27237A1 (is)
WO (1)	WO2002079198A1 (is)
YU (1)	YU71403A (is)
ZA (1)	ZA200304671B (is)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU714980B2 (en)	1996-07-24	2000-01-13	Warner-Lambert Company Llc	Isobutylgaba and its derivatives for the treatment of pain
DE60204611T2 (de) *	2001-02-28	2006-05-11	Pfizer Products Inc., Groton	Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
PT1373259E (pt) *	2001-03-30	2005-03-31	Pfizer Prod Inc	Inibidores piridazinona de aldose reductase
AU761191B2 (en) *	2001-05-24	2003-05-29	Pfizer Products Inc.	Therapies for tissue damage resulting from ischemia
AU2003200847A1 (en) *	2002-01-09	2003-07-24	Pfizer Products Inc.	Process and intermediates for pyridazinone antidiabetic agents
US20040092522A1 (en) *	2002-08-15	2004-05-13	Field Mark John	Synergistic combinations
US7419981B2 (en) *	2002-08-15	2008-09-02	Pfizer Inc.	Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
US6872833B2 (en) *	2003-04-14	2005-03-29	Hoffmann-La Roche Inc.	Adenosine receptor ligands
US8017634B2 (en)	2003-12-29	2011-09-13	President And Fellows Of Harvard College	Compositions for treating obesity and insulin resistance disorders
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
AR049384A1 (es)	2004-05-24	2006-07-26	Glaxo Group Ltd	Derivados de purina
CA2568640C (en)	2004-06-04	2011-08-09	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060035251A1 (en) *	2004-06-30	2006-02-16	Whitehead Institute For Biomedical Research	Novel methods for high-throughput genome-wide location analysis
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
AU2007206016A1 (en) *	2006-01-13	2007-07-26	Wyeth	Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
EP2431367A3 (en)	2006-06-27	2012-07-04	Takeda Pharmaceutical Company Limited	Fused cyclic compounds as GPR40 receptor modulators
ATE547394T1 (de)	2006-12-01	2012-03-15	Bristol Myers Squibb Co	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2008116107A2 (en) *	2007-03-21	2008-09-25	Takeda San Diego, Inc.	Piperazine derivatives as glucokinase activators
JP2010043063A (ja)	2008-05-09	2010-02-25	Agency For Science Technology & Research	川崎病の診断及び治療
CA2783699C (en)	2009-12-08	2019-01-15	Case Western Reserve University	Primary amine compounds for treating ocular disorders
US8916563B2 (en)	2010-07-16	2014-12-23	The Trustees Of Columbia University In The City Of New York	Aldose reductase inhibitors and uses thereof
RU2615767C2 (ru) *	2011-09-15	2017-04-11	Тайпей Медикл Юнивесити	Способ лечения сердечной недостаточности и поражения нервных клеток
US9339542B2 (en) *	2013-04-16	2016-05-17	John L Couvaras	Hypertension reducing composition
CA2909442A1 (en)	2013-04-17	2014-10-23	Pfizer Inc.	N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CN103739547B (zh) *	2014-01-03	2015-09-02	沈阳药科大学	2-[6-甲氧基-3-(2,3-二氯苯基)甲基-4-氧代-1,4-二氢-1(4h)-喹啉基]乙酸的合成方法
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
EP3283074A4 (en) *	2015-04-14	2018-12-05	Case Western Reserve University	Compositions and methods of modulating short-chain dehydrogenase activity
WO2017168174A1 (en)	2016-04-02	2017-10-05	N4 Pharma Uk Limited	New pharmaceutical forms of sildenafil
CN109310674B (zh)	2016-06-21	2022-07-08	纽约市哥伦比亚大学理事会	醛糖还原酶抑制剂及其使用方法
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
US10344002B2 (en)	2016-09-26	2019-07-09	Nusirt Sciences, Inc.	Compositions and methods for treating metabolic disorders
EP3548035A4 (en)	2016-11-30	2020-07-22	Case Western Reserve University	COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
CN110573154A (zh)	2017-02-06	2019-12-13	卡斯西部储备大学	调节短链脱氢酶活性的组合物和方法
IL272246B1 (en)	2017-07-28	2025-09-01	Applied Therapeutics Inc	Derivatives of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as aldose reductase inhibitors in treating galactosemia or preventing complications associated with galactosemia
SG11202105345TA (en)	2018-11-21	2021-06-29	Univ Case Western Reserve	Compositions and methods of modulating short-chain dehydrogenase activity
EP4470609A3 (en)	2019-01-18	2025-03-12	Astrazeneca AB	Pcsk9 inhibitors and methods of use thereof
CN113966396A (zh)	2019-05-07	2022-01-21	迈阿密大学	遗传性神经病和相关障碍的治疗和检测
MX2021014441A (es)	2019-05-31	2022-01-06	Ikena Oncology Inc	Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
WO2020243415A2 (en)	2019-05-31	2020-12-03	Ikena Oncology, Inc.	Tead inhibitors and uses thereof
WO2022120353A1 (en) *	2020-12-02	2022-06-09	Ikena Oncology, Inc.	Tead inhibitors and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE47592B1 (en)	1977-12-29	1984-05-02	Ici Ltd	Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4939140A (en)	1985-11-07	1990-07-03	Pfizer Inc.	Heterocyclic oxophthalazinyl acetic acids
US4996204A (en)	1989-05-11	1991-02-26	Pfizer Inc.	Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
FR2647676A1 (fr)	1989-06-05	1990-12-07	Union Pharma Scient Appl	Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
KR950001039B1 (ko) *	1990-11-30	1995-02-08	가부시끼가이샤 쓰무라	크로몬 유도체 및 이 화합물을 유효성분으로 하는 아르도스 리덕타제 저해제
FI934222A7 (fi)	1991-03-28	1993-09-27	Pfizer	Pyridatsinonietikkahappoja
US5834466A (en)	1994-12-22	1998-11-10	The Regents Of The University Of California	Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
TWI238064B (en)	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
EE04494B1 (et) *	1997-09-24	2005-06-15	Orion Corporation	1-oksa-, asa- ja tianaftaleen-2-oon biseetrid fosfolambaani inhibiitoritena
FR2822827B1 (fr) *	2001-03-28	2003-05-16	Sanofi Synthelabo	Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
PT1373259E (pt) *	2001-03-30	2005-03-31	Pfizer Prod Inc	Inibidores piridazinona de aldose reductase
CN1505514A (zh) *	2001-04-30	2004-06-16	�Ʒ�	醛糖还原酶抑制剂与环加氧酶-2抑制剂的组合
AU2003200847A1 (en) *	2002-01-09	2003-07-24	Pfizer Products Inc.	Process and intermediates for pyridazinone antidiabetic agents

2002
- 2002-01-31 PT PT02716247T patent/PT1373259E/pt unknown
- 2002-01-31 ES ES04023149T patent/ES2274369T3/es not_active Expired - Lifetime
- 2002-01-31 AT AT04023150T patent/ATE352551T1/de not_active IP Right Cessation
- 2002-01-31 ES ES02716247T patent/ES2231681T3/es not_active Expired - Lifetime
- 2002-01-31 UA UA2003098846A patent/UA73236C2/uk unknown
- 2002-01-31 AU AU2002226634A patent/AU2002226634B2/en not_active Ceased
- 2002-01-31 PL PL02365294A patent/PL365294A1/xx not_active Application Discontinuation
- 2002-01-31 OA OA1200300222A patent/OA12453A/en unknown
- 2002-01-31 EP EP02716247A patent/EP1373259B1/en not_active Expired - Lifetime
- 2002-01-31 DK DK02716247T patent/DK1373259T3/da active
- 2002-01-31 AT AT02716247T patent/ATE286049T1/de active
- 2002-01-31 EE EEP200300470A patent/EE200300470A/xx unknown
- 2002-01-31 DE DE60216823T patent/DE60216823T2/de not_active Expired - Fee Related
- 2002-01-31 YU YU71403A patent/YU71403A/sh unknown
- 2002-01-31 HR HR20030752A patent/HRP20030752A2/hr not_active Application Discontinuation
- 2002-01-31 KR KR1020037012753A patent/KR100586138B1/ko not_active Expired - Fee Related
- 2002-01-31 EP EP04023150A patent/EP1491541B1/en not_active Expired - Lifetime
- 2002-01-31 JP JP2002577823A patent/JP2004528319A/ja active Pending
- 2002-01-31 SI SI200230071T patent/SI1373259T1/xx unknown
- 2002-01-31 CA CA002442476A patent/CA2442476A1/en not_active Abandoned
- 2002-01-31 GE GE5314A patent/GEP20053675B/en unknown
- 2002-01-31 HU HU0303644A patent/HUP0303644A3/hu unknown
- 2002-01-31 EA EA200300673A patent/EA006023B1/ru not_active IP Right Cessation
- 2002-01-31 PT PT04023149T patent/PT1491540E/pt unknown
- 2002-01-31 CN CNB028076001A patent/CN1215067C/zh not_active Expired - Fee Related
- 2002-01-31 EP EP04023149A patent/EP1491540B1/en not_active Expired - Lifetime
- 2002-01-31 MX MXPA03008850A patent/MXPA03008850A/es active IP Right Grant
- 2002-01-31 AT AT04023149T patent/ATE348100T1/de not_active IP Right Cessation
- 2002-01-31 DE DE60202452T patent/DE60202452C5/de not_active Expired - Fee Related
- 2002-01-31 BR BR0208571-2A patent/BR0208571A/pt not_active IP Right Cessation
- 2002-01-31 NZ NZ528406A patent/NZ528406A/en unknown
- 2002-01-31 IL IL15646202A patent/IL156462A0/xx unknown
- 2002-01-31 WO PCT/IB2002/000320 patent/WO2002079198A1/en not_active Ceased
- 2002-01-31 DE DE60217930T patent/DE60217930T2/de not_active Expired - Fee Related
- 2002-01-31 DK DK04023149T patent/DK1491540T3/da active
- 2002-01-31 SK SK1185-2003A patent/SK11852003A3/sk unknown
- 2002-03-21 US US10/104,664 patent/US6579879B2/en not_active Expired - Fee Related
- 2002-03-22 PA PA20028541801A patent/PA8541801A1/es unknown
- 2002-03-27 AR ARP020101134A patent/AR035798A1/es unknown
- 2002-03-27 MY MYPI20021093A patent/MY134304A/en unknown
- 2002-03-27 UY UY27237A patent/UY27237A1/es not_active Application Discontinuation
- 2002-03-27 PE PE2002000246A patent/PE20030007A1/es not_active Application Discontinuation
- 2002-03-28 AP APAP/P/2002/002461A patent/AP2002002461A0/en unknown
- 2002-03-29 TN TNTNSN02037A patent/TNSN02037A1/fr unknown
- 2002-03-29 TW TW091106386A patent/TWI245762B/zh not_active IP Right Cessation
- 2002-03-31 CZ CZ20032563A patent/CZ20032563A3/cs unknown
2003
- 2003-02-20 US US10/370,895 patent/US6849629B2/en not_active Expired - Fee Related
- 2003-06-16 IS IS6845A patent/IS2205B/is unknown
- 2003-06-17 ZA ZA200304671A patent/ZA200304671B/en unknown
- 2003-06-25 EC EC2003004671A patent/ECSP034671A/es unknown
- 2003-09-17 MA MA27314A patent/MA27003A1/fr unknown
- 2003-09-17 BG BG108179A patent/BG108179A/xx unknown
- 2003-09-29 NO NO20034345A patent/NO20034345L/no unknown
2006
- 2006-01-23 IS IS8251A patent/IS8251A/is unknown
- 2006-01-23 IS IS8250A patent/IS8250A/is unknown

Also Published As

Publication number	Publication date
EP1491541B1 (en)	2007-01-24
DE60202452C5 (de)	2006-11-23
EP1491540B1 (en)	2006-12-13
EP1491541A1 (en)	2004-12-29
IS2205B (is)	2007-02-15
UY27237A1 (es)	2002-12-31
GEP20053675B (en)	2005-11-25
ATE348100T1 (de)	2007-01-15
SI1373259T1 (en)	2005-04-30
AU2002226634B2 (en)	2007-01-25
AP2002002461A0 (en)	2002-06-30
DE60217930T2 (de)	2007-10-18
CA2442476A1 (en)	2002-10-10
DE60202452T2 (de)	2006-02-09
OA12453A (en)	2006-05-24
IL156462A0 (en)	2004-01-04
BG108179A (en)	2004-09-30
DE60216823T2 (de)	2007-10-04
HK1061678A1 (en)	2004-09-30
MA27003A1 (fr)	2004-12-20
EE200300470A (et)	2004-02-16
EA006023B1 (ru)	2005-08-25
PA8541801A1 (es)	2002-10-28
DK1373259T3 (da)	2005-03-29
EP1373259B1 (en)	2004-12-29
IS8250A (is)	2006-01-23
ECSP034671A (es)	2003-08-29
KR100586138B1 (ko)	2006-06-07
BR0208571A (pt)	2004-03-23
CN1500087A (zh)	2004-05-26
DK1491540T3 (da)	2007-03-26
JP2004528319A (ja)	2004-09-16
UA73236C2 (en)	2005-06-15
ATE352551T1 (de)	2007-02-15
DE60202452D1 (de)	2005-02-03
PE20030007A1 (es)	2003-01-28
ES2231681T3 (es)	2005-05-16
US6849629B2 (en)	2005-02-01
ZA200304671B (en)	2004-06-25
DE60216823D1 (de)	2007-01-25
NZ528406A (en)	2004-03-26
TWI245762B (en)	2005-12-21
MY134304A (en)	2007-12-31
NO20034345D0 (no)	2003-09-29
WO2002079198A1 (en)	2002-10-10
CN1215067C (zh)	2005-08-17
KR20030088484A (ko)	2003-11-19
EP1491540A1 (en)	2004-12-29
ES2274369T3 (es)	2007-05-16
AR035798A1 (es)	2004-07-14
IS8251A (is)	2006-01-23
TNSN02037A1 (fr)	2005-12-23
NO20034345L (no)	2003-09-29
PT1491540E (pt)	2007-01-31
US6579879B2 (en)	2003-06-17
HRP20030752A2 (en)	2005-06-30
EP1373259A1 (en)	2004-01-02
HUP0303644A2 (hu)	2004-03-01
MXPA03008850A (es)	2003-12-04
US20030162784A1 (en)	2003-08-28
EA200300673A1 (ru)	2003-12-25
HUP0303644A3 (en)	2008-06-30
YU71403A (sh)	2006-05-25
PL365294A1 (en)	2004-12-27
CZ20032563A3 (cs)	2004-05-12
SK11852003A3 (sk)	2004-07-07
ATE286049T1 (de)	2005-01-15
US20020143017A1 (en)	2002-10-03
PT1373259E (pt)	2005-03-31
DE60217930D1 (de)	2007-03-15

Publication	Publication Date	Title
IS8250A (is)	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar
DK1421841T3 (da)	2007-12-17	Mejetærsker
DE60212857D1 (de)	2006-08-10	Thermischer schnappschalter
DK1361880T3 (da)	2006-01-23	6-substituerede pyrido-pyrimidiner
PT1411764E (pt)	2005-05-31	Cerca
DE60207168D1 (de)	2005-12-15	Lüftungsanlage
NO20042742L (no)	2004-08-24	Pyrimidinforbindelser
NO20031562D0 (no)	2003-04-07	Vinterdekk
DE60216425D1 (de)	2007-01-11	Ausgleichswellenzusammenbau
DE60210848D1 (de)	2006-06-01	Verbinder
DE50200795D1 (de)	2004-09-16	Mikroventil
DE50210548D1 (de)	2007-09-06	Spannbaugruppe
DE60221366D1 (de)	2007-09-06	Verbinder
DE60233695D1 (de)	2009-10-29	Verbinder
DE60231053D1 (de)	2009-03-19	Stirlingmaschinenzusammenbau
DE50108179D1 (de)	2005-12-29	Verbinder
ATE405973T1 (de)	2008-09-15	Steckverbindung
DE60126833D1 (de)	2007-04-05	Flugzeugsitzkonstruktion
ES1050823Y (es)	2002-09-16	Casco salvavidas
DE10295574D2 (de)	2004-10-28	Geräusch-gesteuertes Beatmungsgerät
FI5142U1 (fi)	2001-11-28	Jänisräikkä
UA5367S (uk)	2001-11-15	Навіс
FI20011758A0 (fi)	2001-09-05	Henkilökohtainen virtsauslaite
NO20010670D0 (no)	2001-02-08	SMS pengeinnsamling
FI5472U1 (fi)	2002-07-30	Puhelaite